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Abstract: The isolation and analysis of circulating biomarkers, the main concern of liquid biopsy,
could greatly benefit from microfluidics. Microfluidics has indeed the huge potentiality to bring liquid
biopsy into the clinical practice. Here, two polydimethylsiloxane (PDMS)-based microdevices are
presented as valid tools for capturing microRNAs biomarkers from clinically-relevant samples. After
an extensive study of functionalized polydimethylsiloxane (PDMS) properties in adsorbing/eluting
microRNAs, the best conditions were transferred to the microdevices, which were thoroughly
characterized. The channels morphology and chemical composition were measured, and parameters
for the automation of measures were setup. The best working conditions were then used with
microdevices, which were proven to capture microRNAs on all channel surfaces. Finally, microfluidic
devices were successfully validated via real-time PCR for the detection of a pool of microRNAs related
to non-small cell lung cancer, selected as proof-of-principle. The microfluidic approach described
here will allow a step forward towards the realization of an efficient microdevice, possibly automated
and integrated into a microfluidic lab-on-a-chip with high analytical potentialities.
Keywords: PDMS microdevice; surface functionalization; microRNAs
1. Introduction
In recent years, the concept of a non-invasive but specific diagnostic analysis, able to detect
minimal amount of biomarkers at the early stages of a pathology, has grown enormously. In fact,
the ability to tailor medical care to an individual patient is connected to the possibility of collecting
information on that individual, starting from low amount of biological samples, to be collected
throughout time. To this regard, liquid biopsy is gaining significant attention for biomarker analysis
and discovery, especially for pathologies like cancer [1,2]. In this context, microfluidic technologies
offer great potential to revolutionize the way for sampling, sample separation, mixing, chemical
reaction, and detection of biomarkers in clinical settings. Several examples of microfluidics applied to
biomedical field are present in the literature [3–5], from the identification of cancer biomarkers such as
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circulating tumor cells, circulating tumor DNA and extracellular vesicles [6,7] to single cell analysis [8]
and organ-on-a-chip technology [7,9], to nucleic acid diagnostics [10–12].
Among different materials suitable for microsystem fabrication, polydimethylsiloxane (PDMS) has
been widely used in a variety of microfluidic applications, including for manufacturing lab-on-a-chip
and micro total analysis systems [13]. PDMS, a silicone-based organic elastomer, is indeed a low-cost,
flexible, optically transparent, and easily processing material [14]. This polymer is greatly employed
for microfluidics and flexible affinity sensing platform [15], due to many advantages, such as
miniaturization aimed at reducing the amount of samples and reagents, minimize time and cost,
improve reproducibility, automate separations and detections. Different microfluidic platforms based
on PDMS have been proposed to provide microchannels or microchambers for purification, processing
and sensing of analytes, to achieve separation and detection with high resolution and sensitivity [15].
Moreover, PDMS is recognized as a highly biocompatible material [16,17], which has the intrinsic
capacity of spontaneously and strongly adsorb nucleic acids [18,19]. This effect becomes more evident
when PDMS surfaces are endowed with positive charges [20], a modification easily performed due
to the capability of this material to undergo functionalization with silane groups [21]. Not only the
functionalization of PDMS is easily obtained, but also PDMS itself can be used to introduce novel
properties on other polymeric materials [22].
Our group already demonstrated the huge potentialities of PDMS-based microdevices for the
purification and analysis of biomarkers [11,19]. Here, two configurations of spiral-shaped microdevices
are presented. The two configurations have different geometries, which display different surface to
volume (S/V) ratios. This aspect is particularly important since a microfluidic device with higher S/V
could adsorb higher amounts of biomarkers and, possibly, capture a higher amount of rare microRNAs.
The capture of microRNAs occurs on the microdevice surfaces, which are functionalized with positive
charges able to attract the negative charges present on the phosphate groups of the microRNA backbones.
After an extensive study of PDMS properties in adsorbing/eluting microRNAs, the best conditions
were transferred to two types of microfluidic devices, which were deeply characterized. The best
working conditions were then validated via real-time PCR for the detection of a pool of microRNAs
related to non-small cell lung cancer (NSCLC), selected as proof-of-principle of a biological application.
2. Materials and Methods
2.1. Materials
(3-Aminopropyl)trimethoxysilane (APTMS), trichlorosilane and ethanol 99.8% were acquired
from Sigma-Aldrich. 2-[Methoxy-(polyethyleneoxy)pro-pyl]trimethoxysilane, tech-90, with
6–9 C2H4O units, called PEG-s, was acquired from Fluorochem (UK), while polydimethylsiloxane
(PDMS) (SYLGARD® 184 elastomer) was obtained from Dow Corning Corporation (USA).
ThermoFisher Scientific supplied the TaqMan® MicroRNA Reverse Transcription Kit, the TaqMan®
MicroRNA Assay-hsa-20a, 222 and 320, the TaqMan® Universal PCR Master Mix. Synthetic
fluorescently-labelled hsa-miR-1246 (5′-TAMRA-AAUGGAUUUUUGGAGCAGG-3′, herein named
miR-1246-TAMRA), as well as synthetic miR-20a (5′-UAAAGUGCUUAUAGUGCAGGUAG-3′), miR-222
(5′-AGCUACAUCUGGCUACUGGGU-3′) and miR-320 (5′-AAAAGCUGGGUUGAGAGGGCGA-3′)
were purchased from IDT Integrated DNA Technologies (Belgium). Distilled DNAse/RNAse free water
(named water herein) was acquired from Gibco™ (USA). Finally, the APL 1 buffer derived from the
QIAamp UCP Pure Pathogen Blood kit and called “lysis buffer”, was provided by Qiagen (Germany).
2.2. PDMS Planar Surfaces Fabrication
PDMS flat surfaces were produced by spin coating [20]. Briefly, 10 parts of PDMS base were mixed
with 1 part of its curing agent, the mixture was hand stirred for 5 min and subsequently degassed
for 30 min under vacuum until bubble-free. Silicon substrates (1 × 1 cm2) were employed as support.
Silicon dice underwent an argon plasma treatment of 2 min at 2 mbar with an RF coil applied power of
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10.5 W to remove organic contaminants and hydroxylate the surface, thus allowing PDMS to better
adhere. Silicon substrates were subsequently coated with PDMS by means of a spin coater (Model
WS400B-6NPP/LITE, Laurell Technologies Corporations, North Wales, PA, USA) using the following
protocol: 5 s at 2000 rpm and 1 min at 6000 rpm. Finally, surfaces were cured in a convection oven
(BINDER Inc., Tuttlingen, Germany) at 110 ◦C for two hours to allow PDMS polymerization.
2.3. pH Dependent Functional Assay on Amino-Silanized PDMS Planar Surfaces
PDMS planar surfaces were functionalized with a silane mixture (named AS), containing 0.1% v/v
APTMS and 0.9% v/v PEG-s silane through a wet functionalization procedure. Prior to silanization,
in order to remove contaminants and favor the exposure of their hydroxyl groups, PDMS substrates
were treated with an argon plasma for 2 min at 2 mbar with an RF coil applied power of 10.5 W. Shortly
after plasma treatment, PDMS surfaces were incubated with the organosilane mixture dissolved in
absolute ethanol in a hermetic glass kettle for 10 min at 60 ◦C. After the reaction, the PDMS surfaces
were rinsed three times in ethanol and dried with nitrogen.
To assess the ability of PDMS surfaces to adsorb and release microRNAs, a functional microRNA
adsorption assay with synthetic TAMRA-conjugated miRNA mimics was performed. A total of 10 ng
of miR-1246-TAMRA dissolved in buffers at different pH but with the same ionic strength (i.e., 20 mM)
or dissolved in water, were incubated on the surface for 20 min at room temperature to allow the
optimal adsorption of miRNA. After incubation, the unbound material was removed and the surfaces
underwent three washing steps with the same buffer as incubation. The remaining microRNA adsorbed
by the surface was visualized and analyzed by fluorescence microscopy using a Leica DMLA (Leica
Microsystems, Germany), equipped with a mercury lamp and fluorescence filter L5 (Leica Microsystems,
Germany). All substrates were observed with a 20× magnification objective and measured with a
cooled charge-coupled device (CCD) camera (DFC 420C, Leica Microsystems, Germany). After imaging,
surfaces were subjected to a release step by incubating with buffers either at pH 5, 7 or 9 (all with
20 mM ionic strength) for 10 min at room temperature. At the end of this step, the released material was
removed and surfaces were imaged again as described before. For both imaging, i.e., after adsorption
and after release of microRNAs, sampling was performed at least in triplicates for each surface and
images were analyzed with Fiji software [23].
2.4. PDMS Microdevices Fabrication
The two types of microfluidic devices were fabricated as follows: an upper PDMS reaction
chamber was obtained by mold-casting and subsequently bonded on a silicon support coated by a thin
layer of PDMS. The reaction chamber was designed (Figure 1, Panels (a) and (b)) by a 3D computer
aided design (CAD) software (Rhinoceros®) and molded over a spiral shaped template fabricated with
SU-8 photolithography on a silicon wafer support (Figure 1, Panel (c)). In details, the first spiral device
(from now called Chip A) was designed with a squared channel with section of 200 µm wide and
200 µm deep, with walls spacing width of 200 µm. The second device (from now called Chip B) was
defined by a rectangular cross section 60 µm wide and 200 µm deep with walls spacing 150 µm wide.
The total length of the spiral channel differs for the two microfluidic devices, being 353 mm for Chip A
and 1078 mm for Chip B. The spiral channel is connected with the exterior by two inlet/outlet holes.
The fabrication of PDMS microfluidic devices started with the preparation of the SU-8 mold,
as explained below. Firstly, silicon wafer support was coated by SU-8 (Microchemicals GmbH) using a
spin coater (Spinner 150 WAFER SPINNER) by setting 10 s at 500 rpm and 60 s at 2000 rpm. Then
a soft bake process in two thermal steps was performed: the first step at 65 ◦C for 8 min and the
second at 95 ◦C for 80 min, both on the hot plate. The SU-8 was exposed for 30 s to standard UV
photolithography by means of a double side mask aligner (Neutronix Quintel NXQ 4006) used in
contact mode, ensuring the correct alignment between the SU-8 and the desired mask patterns. The post
bake was characterized again by two thermal steps: the first at 65 ◦C for 5 min and the second at 95 ◦C
for 25 min, on a hot plate. After that, the SU-8 was developed using Propylene glycol methyl ether
Appl. Sci. 2020, 10, 3867 4 of 17
acetate (PGMEA) for 20 s to obtain the finished mold. Finally, the released SU-8 structures were hard
baked at 170 ◦C for 15 min. To guarantee the correct detachment of PDMS from the mold, a silanization
step with trichloromethylsilane (CH3Cl3Si) and toluene in a 1:10 ratio was performed on mold surface.
Before silanization, the SU-8 mold was subjected to an O2 plasma treatment (300 W, O2 30%, 1 min).
Next, mold surfaces were silanized through a wet phase for 4 h, then rinsed with 2-propanol and
dehydrated on a hot plate at 170 ◦C for 10 min.
Figure 1. Computer aided design (CAD) representation of the channels featured in the two types of
microdevices (Chip A in Panel (a) and Chip B in Panel (b)) used in this study. Panel (c): a wafer before
dicing in single microdevices. Panel (d): experiment workflow. The microdevice is placed in a proper
holder with inlet tube fed by a microsyringe pump and outlet tube to collect cDNA for RT-PCR analysis.
To perform the mold casting of the reaction chamber, PDMS was prepared by hand mixing the
pre-polymer and the curing agent in a 10:1 ratio, followed by a degassing step after which PDMS
was poured on the mold. Curing reaction was performed at 120 ◦C for 15 min. The freshly cured
spiral chambers were cleaned with acetone and 2-propanol, and dehydrated on a hotplate at 70 ◦C
for 5 min. In the meantime, the silicon wafer acting as support was pre-cut, cleaned with sulphuric
acid and hydrogen peroxide solution (3:1 v/v ratio) for 5 min, rinsed 3 times in water and dried with
nitrogen. The silicon support was coated with a thin layer of PDMS by means of a spin coater (Spinner
150 WAFER SPINNER) with the following protocol: 5 s at 500 rpm and 60 s at 3000 rpm and cured at
120 ◦C on a hot plate for 5 min. The spiral chambers were bonded on the silicon support by means
of a standard O2 plasma treatment (300 W, O2 60%, 2 min). Once assembled, microfluidic devices
were put at 90 ◦C for an hour in the oven. Figure 1 shows the PDMS microdevices and a scheme of
experiment workflow.
Appl. Sci. 2020, 10, 3867 5 of 17
2.5. Microdevices Characterization
The microdevice cross sections were characterized with a field emission scanning electron microscopy
(Zeiss Supra 40 FE-SEM) to check the quality of microchannels. The PDMS microdevices were cut
perpendicular to the pattern and then metalized with Chromium to allow the FE-SEM characterization.
The chemical characterization was carried out by X-ray photoelectron spectroscopy (XPS).
XPS measurements were performed using a Kratos Axis Ultra DLD instrument (Kratos Analytical,
Manchester, UK) equipped with a hemispherical analyzer and a monochromatic Al Kα (1486.6 eV)
X-ray source, in spectroscopy mode. PDMS planar surface and microdevices were analyzed with a
take-off angle between the analyzer axis and the sample surface of 0◦, corresponding to a sampling
depth of approximately 10 nm. For each microdevice sample, a survey (in the 1300, −5 eV energy range)
was recorded inside and outside channels in order to check for the presence of impurities derived from
the fabrication process. Charge compensation was achieved using a charge neutralizer located at the
bottom of the electrostatic input lens system. Survey spectra were aligned setting C 1s core level peak
at 284.38 eV, the PDMS value in the literature [24]. The quantification, reported as relative elemental
percentage, was carried out extracting core levels from the survey spectra. All XPS data were analyzed
using the software described in Speranza and Canteri [25].
2.6. Microdevices Functionalization and Set up of Working Conditions
Prior to silanization, the internal surfaces of the PDMS microdevices were treated with an
argon plasma for 2 min at 2 mbar with an RF coil applied power of 10.5 W. Shortly after plasma
treatment, PDMS microdevices were placed in a proper holder and inlet and outlet tubes were inserted
(Figure 1, Panel (d)). The inlet tube was connected to a microsyringe (Legato 185, KD Scientific,
Holliston, MA, USA), to deliver liquids with specific flow rates in all steps of this work. Organosilane
mix, made of 0.1% v/v APTMS and 0.9% v/v PEG-s diluted in ethanol, was fluxed at 10 µL/min to
fill the microdevice. Once full, the microdevice was placed in a water bath at 60 ◦C and the mix was
continuously fluxed at 2 µL/min for 5 additive minutes. In setup experiments, the silanization time was
changed in order to find the optimal conditions. The excess of organosilanes mixture was then removed
by fluxing 10 volumes of ethanol followed by 10 volumes of water, both at 25 µL/min. Flux rate of
microRNAs insertion and washing were optimized by changing the microsyringe parameters.
2.7. On-Chip microRNAs Functional Assay and Real-Time PCR
To explore the microdevices performances, a functional assay with synthetic miRNA-1246-TAMRA
was setup. Briefly, the fluorescently-labelled miR-1246 spiked either in water or human plasma, was
inserted in the microdevice, normally at 10 µL/min flow rate. After a wash with water at 1 µL/min for
10–15 min, the adsorbed microRNA was imaged either by fluorescence or confocal microscopy. For the
fluorescence microscopy imaging, a Leica DMLA microscope (Leica Microsystems, Wetzlar, Germany),
equipped with a mercury lamp and fluorescence filter L5 (Leica Microsystems, Wetzlar, Germany)
was employed. All microdevices were observed with a 2.5×magnification objective and measured
with a cooled CCD camera (DFC 420C, Leica Microsystems, Wetzlar, Germany). To acquire images
covering the whole chip, the microscope motorized stage was controlled through a BeanShell script
running in MicroManager (version 1.4.23, micro-manager.org), acquiring 54 tiles for each image.
The reconstruction of images as well as all the analyses were performed with the Fiji software [23] and
Fiji custom macros. The confocal imaging was performed with a Leica SP5-II confocal microscope (Leica
Instruments, Wetzlar, Germany), equipped with a helium/neon (543 nm) laser. Samples were observed
utilizing a 20× objective, while to help the microRNAs visualization on walls, microdevice channels
were cut at 30◦. To acquire the TAMRA signal, fluorophores were excited with the helium/neon laser,
using an emission detector wavelength range from 570 to 660 nm.
On-chip miRNA purification and detection was validated with synthetic miRNAs dissolved in
water or in blood plasma. Purification of synthetic microRNAs was performed by spiking synthetic
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microRNAs ranging from 0.1 pg to 1 ng either in water or in human plasma mixed in a 1:1 ratio with
lysis buffer (APL1 buffer, Qiagen, Germantown, MD, USA). To obtain human plasma, blood samples
were collected from healthy donors into EDTA-treated collection tubes. For plasma preparation, fresh
blood was centrifuged at 700 g for 10 min to pellet the cell fraction. The supernatant was then collected
avoiding contact with the buffy coat. Before using, plasma samples were centrifuged at 1000 g for
5 min at 4 ◦C to pellet the debris.
The proper amount of synthetic microRNA diluted either in water or in plasma was inserted in the
microdevice at room temperature with the microsyringe at 10 µL/min for a suitable time (10–20 min).
During this step, the microRNA is adsorbed on the amino-silanized surfaces of microdevice channels.
To remove the excess of microRNAs, a wash with water was performed at 1 µL/min for 10–15 min.
For the on-chip analysis of miRNAs, a two-steps protocol based on reverse transcription coupled
with real-time PCR was employed. Reverse transcription (RT) was performed directly on-chip on
the miRNAs adsorbed by the PDMS surface by adding the RT master mix at 10 µL/min into the
microdevice. TaqMan® MicroRNA Reverse Transcription Kit included 100 mM dNTPs (with dTTP),
MultiScribe™ Reverse Transcriptase (50 U/µL), 10× Reverse Transcription Buffer, RNase Inhibitor
(20 U/µL), 20×miR-specific RT primers. The reaction was carried out for 30 min at 16 ◦C, 30 min at
42 ◦C, and 5 min at 85 ◦C on a XP Thermal cycler (Bioer Technology Co., Ltd.) equipped with a flat
thermal block. Once synthetized, cDNA was subsequently recovered from the microdevice with the
help of microsyringes and amplified with TaqMan® MicroRNA Assay—hsa-miR-specific in standard
conditions. An amount of 20 µL of real-time PCR mix were composed of TaqMan® Small RNA Assay
(20×), TaqMan® Universal PCR Master Mix II (2×), nuclease-free water and cDNA, following the
manufacturer’s instructions. The cycling protocol, 95 ◦C for 10 min and 45 cycles of 95 ◦C for 15 s and
1 min at 60 ◦C was run on a CFX Connect™ Real-Time PCR Detection System (BioRad). Samples were
amplified in triplicates and non-templates controls were included (amplification negative control).
Data were analyzed with BioRad CFX Manager 2.1 software and threshold cycles (Ct) were reported
and compared with a standard curve, build with known amounts of cDNA, for quantification.
3. Results and Discussion
The direct adsorption of microRNAs on a PDMS microdevice was already demonstrated by our
group [19,20]. The overall handling, however, was manually driven and therefore further investigations
were needed in order to automatize and improve the performances of the microdevice. In a perspective
of use in clinically relevant environments, the partial or total automatization of a microdevice could
indeed make the difference between research purposes or real-life applications.
3.1. Setup of the Optimal Conditions for microRNAs Adsorption on PDMS Planar Surfaces
PDMS planar surfaces were selected to mimic the surfaces of microdevice channels with the aim of
studying the best pH conditions for microRNAs capture and release. The interaction between primary
amines coating surfaces and nucleic acid is indeed well documented [26,27]. Since the main driving
force of this phenomenon relies on the electrostatic interaction, a change in the pH of nucleic acid
solutions could affect their adsorption. As a first step in the setup of the optimal working conditions, an
investigation on the dependence of microRNA adsorption on pH was therefore undertaken. Moreover,
considering the potential use of this microdevice aimed at biomarker detection, the synthetic miR-1246
was selected because of its suggested potential role as biomarker for several cancer types [28,29],
including the non-small cell lung cancer (NSCLC) [30].
Synthetic miR-1246 conjugated with the fluorescence dye TAMRA was diluted in buffers with
pH ranging from 4 to 9, while the ionic strength was kept constant at 20 mM to minimize the
possible interference of counter-ions or ionic bridges. The fluorescent microRNA was incubated on the
silanized PDMS surfaces. After adsorption and washing, the surfaces were imaged with a fluorescence
microscope. The adsorption of microRNAs was higher at pH around 5, but a quite good adsorption
was observed also at neutral pH (Figure 2, Panel (a)), confirming our previous findings related to
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the behavior of amino-silanized surfaces [27]. Interestingly, the highest adsorption (fluorescence
signal = 26.4 × 103 ± 180) was obtained when the microRNA was diluted in water (i.e., very low ionic
strength, pH slightly acidic). This behavior could be easily explained considering the net charge of the
interacting molecules. In fact, RNA molecules are negatively charged under physiological conditions,
due to the presence of charged phosphate groups along the backbone of the nucleic acid. Under
the same conditions, the majority of the amino groups are in their protonated forms, as discussed
below, so the APTMS exposes a positive surface, prone to attract negative molecules. Instead, at
basic pH the amino groups are mostly in their un-protonated form, thus the APTMS surface becomes
neutral. Moreover, the presence of PEG-s molecules helps the uniform distribution of positive charges,
as demonstrated by our group [19,31].
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at pH 9 was complete also when the microRNA adsorption step occurred in water (the measured
fluorescence value was 25.7 × 103 ± 180).
Experiments run on PDMS planar surfaces took to the conclusion that best conditions for microRNA
adsorption are the dilution in water followed by elution at pH 9. Importantly, the adsorption at
physiological pH is also high, allowing to process biological samples without changing the pH of
solution before microRNA capture.
3.2. Characterization of PDMS Spiral-Shaped Microdevices
Prior to analyze the performances of spiral-shaped microdevices for the capture of microRNAs, a
morphological and chemical characterization was performed. Several microdevices were sectioned
and measured at the Field Emission Scanning Electron Microscope (FESEM) (Figure 3) in order to
check for the real dimensions of microdevice channels. For Chip A, channels were 182 ± 13 µm wide
and 325 ± 88 µm deep, with a mean volume of 20 µL, while for Chip B channels were 60 ± 4 µm wide,
197 ± 13 µm deep and 12 µL as total volume. The two microdevices differed for their surface to volume
ratio (S/V for Chip A is 18.0 mm−1 and for Chip B is 46.2 mm−1).
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Figure 4. X-ray photoelectron spectroscopy (XPS) survey spectra taken at 0◦ take-off angle. Spectra
were taken inside microdevices channels (curves nam d Channel A and Ch nnel B) and outside
channels, i.e., on freshly cut microdevic urfaces (A bulk and B bulk). A planar PDMS surface was
also m asur d for comparison (planar PDMS).
Table 1. XPS relative quantification (%) of O, C, and Si detected with a 0◦ take-off angle on inner
(Channel A or B) and outer surfaces (Chip A or B bulk) of microdevices channels and on PDMS planar
surfaces. The standard error does not exceed the 1–2% of the reported value.
Sample O 1s (%) C 1s (%) Si 2p (%)
Channel A 29.4 51.7 18.6
Chip A bulk 29.7 51.5 18.5
Channel B 29.4 49.9 20.7
Chip B bulk 29.9 50.1 20.0
Planar PDMS 28.8 50.7 20.5
Beside XPS measurements, a PCR was performed in order to verify the compatibility of the
microdevice material with an amplification reaction. Small pieces of microdevice exposing the channel
surface were submerged in the PCR mix and the reaction was run. PCR products were loaded on an
agarose gel (Figure S1) and compared with controls (both tubes without PDMS and tubes containing
small pieces of a PDMS microdevice known for its compatibility with PCR [18,19]). The microdevice
internal surfaces were confirmed as perfectly compatible with the PCR reaction.
3.3. From PDMS Planar Surfaces to Spiral-Shaped Microdevices
The setup of a functional assay on PDMS planar surfaces as well as the characterization of
spiral-shaped microdevices were detailed in the previous paragraphs. These results, however, cannot
be directly utilized to effectively functionalize the microdevices, therefore further experiments were
undertaken. In particular, protocols had to be adapted to the automated microdevice manipulation.
Firstly, the silanization protocol was arranged in order to provide the best performances in terms of
microRNAs adsorption.
The silanization mixture, AS, was injected in the microdevice, which was next immersed in water at
60 ◦C for different periods. A time spanning from few minutes to one hour was employed to functionalize
the microdevices (Figure 5, Panel (a)), while all other functionalization conditions were kept constant.
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Even at short silanization time, a good adsorption of microRNA was observed, allowing selecting 5 min
of silanization as the standard condition for following experiments. This conclusion was reinforced
by measuring the unbound microRNA collected from every microdevice, at the spectrophotometer.
In addition, in this case, the amount of unbound material from microdevices silanized for 5 min was
comparable with those of microdevices silanized for 40 or even for 60 min (Figure S2).
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Figure 5. Optimization of protocols from PDMS planar surfaces to spiral microdevices. Fluorescent
miRNAs were used to assess functionalization parameters. Panel (a): optimization of silanization time.
The microdevice is functionalized with a mixture of 0.1% APTMS and 0.9% PEG-s silane (named AS)
in immersion at 60 ◦C for diff rent times. An amount of 600 ng of fluor nt micr RNAs diluted in
water are then absorbed to microdevice AS surfaces and the resulting fluorescence is reported as a
function of the silanization time. Panel (b): optimization of the flux speed during microRNA insertion.
3 ng/µL miR-1246-TAMRA was inserted either at 2 µL/min x 100 min or 10 µL/min x 20 min. Panels
(c,d): optimization of washes speed after miR adsorption. A total of 600 ng of miR-1246-TAMRA,
diluted in human plasma added with lysis buffer, were incubated on microdevices A (Panel (c)) or B
(Panel (d)); then a wash with water is performed at different fluxes. Relative volumes are reported
(i.e., referred to each chip volume).
Once functionalized, the microdevice is ready to capture microRNAs. Therefore, the next
optimization concerned the flux of microRNA insertion, which should be fast enough to allow the
adsorption on the microdevice surfaces but not too fast impeding the effective contact of microRNAs
with the positively charged surfaces. The same concentration of fluorescent microRNA was inserted in
the silanized microdevices (Figure 5, Panel (b)) with two different flow rates for a sufficient time to
deliver 600 ng of total microRNA. Both the fluxes gave quite similar results in terms of microRNA
adsorption for both the microdevices types (A and B), therefore 10 µL/min was selected as optimal,
reducing the insertion time and speeding up the duration of the assay.
Finally, a washing step is needed to remove the unbound material. The microdevice was flowed
with water, whose pH is slightly acidic (see Section 3.1) and therefore the surface charges are not
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affected. Further, in this case, the flow rate is crucial for removing all the unwanted material but
preserving all the adsorbed microRNA. Moreover, the volume of water used in the washing step
should not exceed the minimum value that is necessary to effectively substitute the channel solution
with water, otherwise the equilibrium of microRNA adsorbed on surfaces could be shifted toward its
release. Two flux rates were applied either to Microdevice A (Figure 5c) or to Microdevice B (Figure 5d)
after the microRNA-capture step. Both fluxes gave similar results, removing the excess of microRNA
solution up to a plateau. However, the flux of 1 µL/min for 10 min was selected as the most efficient in
removing the unbound material, while better preserving the adsorbed microRNA.
An injection time of 10 min, i.e., about one washing volume, was judged compatible with the
overall duration of the assay, while guaranteeing not to remove the adsorbed microRNA. A scheme
visualizing the whole process of microRNA insertion and washing is reported in Figure S3.
In conclusion, moving from planar surfaces to microdevices, the silanization time was reduced to
5 min, the flow rate to insert microRNA was set to 10 µL/min, while the washing flow rate was reduced
to 1 µL/min.
3.4. Functional Assay for the Characterization of Microdevices for microRNA Adsorption
Once set up the working parameters for both microdevices, a functional assay aimed at verifying the
potentialities of the two microdevices types was carried out. In the previous paragraph, all parameters
were set up by measuring the fluorescence signal related to the presence of miR-1246-TAMRA with
a wide-field fluorescence microscope. This method is excellent for a relative comparison of the
different conditions applied to the microdevices, but results rather poor when a strict quantification
is needed. In particular, the collected fluorescence signal is mostly related to the microRNA adsorbed
on channels top and bottom surfaces, with a minor contribution from channels lateral surfaces.
To check the uniformity of miRNA adsorption on surfaces, a confocal microscope was then used to
collect three-dimensional images of the channels for the two kinds of microdevices. Channels of both
microdevices were cut diagonally with an angle of about 30◦ after microRNA adsorption, to ease the
imaging at the confocal microscope (Figure 6).
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Figure 6. Check for surface availability for microRNA adsorption. Panel (a): 1200 ng of miR-1246-
TAMRA diluted in water are adsorbed on functionalized microdevice A. Panel (b): 600 ng of miR-
1246-TAMRA diluted in water are adsorbed on functionalized microdevice B. After washes, the dry 
channels were cut diagonally with an angle of about 30°, as depicted on top of each image (CAD 
Figure Check for surface ava ability for microRNA adsorptio . Panel (a): 1200 ng of
miR-1246-TAMRA dilu d in water ar adsorbed o functionalized microdevic A. Panel (b): 600 ng
of miR-1246-TAMRA diluted in water a e a sorbed on functionalize m rodevic B. Aft r washes,
the dry chann ls were cut diagonally with an angle of about 30◦, as depicted on top of each image
(CAD representations), and imaged at the confocal microscope in z-stacking mode. Images are 3D
reconstructions of microdevice channels.
From data reported in Figure 6, all microdevice surfaces can be considered as properly
functionalized and then available for microRNAs capture. The presence of the fluorescent microRNA,
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indeed, is homogenously distributed on all the visible surfaces, confirming the good working conditions
previously set up.
Next, we moved to consider the effect of the different total channel surface on the maximum
loading capacity of the two kinds of microdevices. In Figure 7, an estimation of the total area covered
by fluorescent miRNAs versus the quantity of miRNAs fluxed through the chip is reported. This
titration confirmed that Microdevice B, which presents a higher total channel surface (S/V ≈ 46.2 mm−1),
adsorbs a higher amount of microRNA compared to Microdevice A (S/V ≈ 18.0 mm−1). For this
experiment all other parameters than concentration, i.e., flux rate, microRNA insertion time, flux and
washing time, were kept constant. The insertion of 300 ng of pure microRNA saturated the capturing
ability of Microdevice A, while a double amount was still well adsorbed by Microdevice B. The total
area possibly occupied by microRNA was calculated as 356 mm2 for Chip A and 460 mm2 for Chip B.
For Chip A, this value was reached with the adsorption of 300 ng of microRNA, while the double was
still adsorbed by Chip B, reflecting the different S/V for the two microfluidic devices. The S/V of Chip B
is indeed about the double than S/V of Chip A.
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Figure 7. Testing microdevices performances in miRNAs adsorption. The adsorption of different
quantities of synthetic fluorescent microRNA (miR-1246-TAMRA) dissolved in water on the two types
of chips is measured as the total spiral length occupied by microRNA after washes.
The ability to capture pure microRNA was demonstrated for both microdevices. A further
characterization of microdevice performances, more geared toward a possible use of these devices
on field, was performed by introducing a constant concentration of fluorescent microRNA spiked
in human plasma added with lysis buffer (Figure 8), for different times. The addition of lysis buffer
is needed to favor the release of miRNA from vesicles encapsulation or protein complexes, in the
perspective of microdevice use with clinically relevant samples. For this analysis, Chip B was selected
as the more performant with respect to the Chip A (Figure 7).
Comparing the fluorescence signal intensity that is detected on microdevices fluxed for different
times, a linear increment is clearly visible as the fluxing time is increased, as expected. This behavior
confirmed that the channel surfaces are able to capture the microRNA even when it is dissolved in a
complex matrix, such as human plasma. Moreover, from the same data, one infers that this capability
is maintained constant in time, leading to the linear increase of captured miRNAs. Blood plasma,
indeed, contains a lot of components (proteins, lipids, small molecules, etc.), which presumably can
be adsorbed to the positively-charged surfaces as well as nucleic acids. These components, however,
do not impede the further adsorption of microRNA on the surface sites still available. This potentiality
Appl. Sci. 2020, 10, 3867 13 of 17
of PDMS-based microdevice was already demonstrated by our group with a different type of PDMS
microdevice with a limited surface available for microRNA capture [19,20]. The augmented surface
of the here presented microdevices together with their handling automation could help to introduce
similar microdevices for the use in real setting.
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3.5. Validation of PDMS-Based Microdevices
Final application of the PDMS-based microdevices presented in this study is the specific capture
of low amounts of microRNAs as biomarkers of oncological pathologies in the context of liquid
biopsy. Since the concentration of such circulating biomarkers is quite low, a polymerase chain reaction
amplification step is required. The adsorbed miRNAs were directly reverse-transcribed on-chip, then
releasing cDNA molecules in solution. This solution was collected to feed the DNA amplification step,
using standard tubes and equipment.
A panel of microRNAs often referred as biomarkers of NSCLC [39,40] was selected to validate
the microdevices. Either microRNA-20a or microRNA-222 or even microRNA-320 were spiked in
water or in human plasma added with lysis buffer and subjected to purification via adsorption
on the functionalized microdevices. After the washing step with water to remove the unwanted
material possibly adsorbed on channel walls, the proper reverse transcription mix was inserted in each
microdevice and the reaction was allowed to proceed directly on-chip on a thermal cycler equipped
with a flat thermal block, as previously described [19]. Finally, the solution containing the proper
cDNAs was used to feed the RT-qPCR reactions (Figure 9). For all the tested conditions, a decrease in
the threshold cycles (Ct) is observed when the amount of spiked microRNA increases. Interestingly,
the same amount of spiked microRNA gave different results when spiked in water or in plasma, with a
better Ct in plasma. A possible explanation of this phenomenon relies on the passivation effect due to
proteins present in plasma but, obviously, absent when the microRNA is dissolved in water. In other
words, the components of a biological sample not only do not adversely compete with microRNA
molecules for the adsorption sites, but favor instead their better interaction with the channel surfaces.
Same amount of functional sites are initially available on channel surfaces for the two conditions, but
in water more anchorage free sites could capture in a constrained conformation the microRNA with
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respect to that in plasma. As a result, this microRNA could be not completely available for the enzyme
in the reverse transcription step, yielding a lower amount of cDNA molecules to be amplified via
RT-qPCR. Moreover, components of the reverse transcription mix as well as the just-copied cDNA
molecules could also be captured on non-passivated chip surfaces.
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4. Conclusions
The present study shows the fabrication, characterization and functional application of two
spiral-shaped microdevices. The PDMS microdevices have different surface to volume ratios and
differ for the total internal surface available for the capture of biomarkers. The microfluidic device
presenting a higher S/V was demonstrated to capture a higher amount of microRNAs. This aspect is
especially important since biomarkers, in particular microRNAs, are present in little amounts in body
fluids and therefore, a smart method for concentrating and detecting is welcome. The microdevices
presented here satisfy this requirement, being able to purify different microRNAs considered as cancer
biomarkers from a biological fluid, such as human plasma. The performances of the microdevices
approached or even exceeded those of a similar PDMS-based microdevices previously reported in the
literature. This consideration fosters the idea of a real use of PDMS-based microdevices as diagnostic
tools to identify low abundant microRNA biomarkers in clinical setting.
Liquid biopsy is indeed emerging as a precious source of biomarkers, easily accessible and
therefore useful for mass screening and for biomarkers profiling of patients during specific therapies.
Microfluidic devices could simplify liquid biopsy, allowing the spread of these methodologies not only
for diagnostic purposes, but also for following the progress of a disease. Moreover, the detection of low
amounts of biomarkers could take to earlier diagnosis of pathologies with a possible better outcome.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-3417/10/11/3867/s1,
Figure S1: PCR assay to test PDMS compatibility; Figure S2: optimization of silanization time; Figure S3:
fluorescent microRNAs adsorption on microdevices.
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